This new MP Bio facility will produce biochemicals, cell culture media, liquid formulation, power compounding and other custom manufacturing. The facility will be registered with the US FDA and operate within a Quality Management System (QMS) certified to ISO13485:2016 and compliant with 21 CFR 210, 211, and 820.
